SOAT1 and psoriatic arthritis: Given the increasingly acknowledged implication of the JAK/STAT pathway and its blocking agents (tofacitinib/baricitinib) in the modulation of pain and nociceptive response, the JAK/STAT pathway and nociceptive cytokine signaling in rheumatoid arthritis and psoriatic arthritis are observed [147].